Cite
HARVARD Citation
Giordano, G. et al. (n.d.). 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. European journal of cancer. pp. S444-. [Online].